Surmodics Inc (SRDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
09-2023 | 09-2022 | 09-2021 | 09-2020 | 09-2019 | |
Cash Flows From Operating Activities | |||||
Net Income | -1,536 | -27,274 | 4,237 | 1,123 | 7,592 |
Depreciation Amortization | 8,887 | 9,188 | 8,063 | 7,263 | 7,571 |
Income taxes - deferred | -181 | 5,268 | 1,651 | -1,139 | -1,088 |
Accounts receivable | -977 | -1,522 | -2,480 | 3,461 | -1,630 |
Accounts payable and accrued liabilities | -183 | 1,608 | 264 | -483 | -765 |
Other Working Capital | -4,236 | -12,276 | -4,857 | 1,120 | -9,946 |
Other Operating Activity | 8,740 | 7,785 | 8,511 | 2,665 | 6,304 |
Operating Cash Flow | $10,514 | $-17,223 | $15,389 | $14,010 | $8,038 |
Cash Flows From Investing Activities | |||||
PPE Investments | -2,918 | -3,370 | -5,279 | -3,671 | -6,748 |
Net Acquisitions | N/A | N/A | -40,553 | N/A | N/A |
Purchase Of Investment | -3,904 | N/A | -22,723 | -59,917 | -44,973 |
Sale Of Investment | N/A | 9,600 | 43,317 | 54,522 | 61,458 |
Other Investing Activity | 0 | 0 | 0 | 0 | 17 |
Investing Cash Flow | $-6,822 | $6,230 | $-25,238 | $-9,066 | $9,754 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | N/A | N/A | 10,000 | 0 | N/A |
Debt Issued | 29,664 | N/A | N/A | N/A | N/A |
Common Stock Issued | 1,252 | 1,246 | 3,128 | 1,615 | 723 |
Other Financing Activity | -12,510 | -1,621 | -2,901 | -6,263 | -11,752 |
Financing Cash Flow | $18,406 | $-375 | $10,227 | $-4,648 | $-11,029 |
Exchange Rate Effect | 323 | -787 | -10 | 128 | -70 |
Beginning Cash Position | 18,998 | 31,153 | 30,785 | 30,361 | 23,668 |
End Cash Position | 41,419 | 18,998 | 31,153 | 30,785 | 30,361 |
Net Cash Flow | $22,421 | $-12,155 | $368 | $424 | $6,693 |
Free Cash Flow | |||||
Operating Cash Flow | 10,514 | -17,223 | 15,389 | 14,010 | 8,038 |
Capital Expenditure | -2,918 | -3,370 | -5,279 | -3,671 | -6,748 |
Free Cash Flow | 7,596 | -20,593 | 10,110 | 10,339 | 1,290 |